One of the hallmarks of cancer cells lies in the rapid proliferation and heightened metabolic activity, which often results in the accumulation of reactive oxygen species (ROS) and subsequent mitochondrial dysfunction. In this context, oxyhydrogen emerges as a potent modulator of cellular energetics, exerting a regulatory influence on the transition from aerobic to anaerobic energy production.

By mitigating oxidative stress and bolstering mitochondrial function, oxyhydrogen therapy addresses the metabolic aberrations characteristic of cancer cells, offering a promising avenue for intervention.

Oxyhydrogen's profound anti-inflammatory and antioxidant influences are pivotal in cancer management, targeting critical pathways implicated in tumorigenesis and progression. By dampening inflammatory signalling cascades and neutralising free radicals, oxyhydrogen therapy creates an inhospitable environment for cancer growth and metastasis, thereby augmenting the efficacy of conventional therapeutics.